Income Tax Accounting Policy
Current tax is provided at the amounts expected to be paid applying tax rates that have been enacted or substantively enacted by the balance sheet date.
Deferred tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements. Deferred tax assets are recognized to the extent that it is probable that future taxable profits will be available against which the temporary differences can be utilized. Deferred tax is provided on temporary differences arising on investments in subsidiaries, associates and joint ventures, except where the timing of the reversal of the temporary difference can be controlled and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred tax is provided using rates of tax that have been enacted or substantively enacted by the balance sheet date. Deferred tax liabilities and assets are not discounted.
Source: GlaxoSmithKline PLC, Annual Report
Income Tax Expense (Benefit)
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
GlaxoSmithKline PLC, income tax expense (benefit), continuing operations
USD $ in millions, translated from GBP £
Source: Based on data from GlaxoSmithKline PLC Annual Reports
| Item |
Description |
The company |
| Current taxation |
The component of income tax expense for the period representing amounts of income taxes paid or payable (or refundable) for the period for all income tax obligations as determined by applying the provisions of relevant enacted tax laws to relevant amounts of taxable income (loss) from continuing operations. |
GlaxoSmithKline PLC's current taxation increased from 2008 to 2009 but then declined significantly from 2009 to 2010.
|
| Deferred taxation |
The component of income tax expense for the period representing the net change in the entity's deferred tax assets and liabilities pertaining to continuing operations. |
GlaxoSmithKline PLC's deferred taxation declined from 2008 to 2009 but then slightly increased from 2009 to 2010.
|
| Taxation |
The sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to pretax income (loss) from continuing operations; income tax expense (benefit) may include interest and penalties on tax uncertainties based on the entity's accounting policy. |
GlaxoSmithKline PLC's taxation increased from 2008 to 2009 but then declined significantly from 2009 to 2010.
|
Deferred Tax Assets (Liabilities), Net
You have visited 10 password protected pages for free. Others contain data covered by .
Sign Up Now to get full access to whole website and cut out all advertisements.
GlaxoSmithKline PLC, deferred tax assets (liabilities), net
USD $ in millions, translated from GBP £
Source: Based on data from GlaxoSmithKline PLC Annual Reports
| Item |
Description |
The company |
| Deferred tax assets |
The aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; net of deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. |
GlaxoSmithKline PLC's deferred tax assets declined from 2008 to 2009 but then increased from 2009 to 2010 not reaching 2008 level.
|
| Deferred tax assets (liabilities), net |
For entities that net deferred tax assets and tax liabilities, represents the unclassified net amount of deferred tax assets and liabilities as of the balance sheet date, which result from applying the applicable enacted tax rate to net temporary differences and carryforwards pertaining to assets or liabilities. A temporary difference is a difference between the tax basis of an asset or liability and its carrying amount in the financial statements prepared in accordance with generally accepted accounting principles that will reverse in ensuing periods. |
GlaxoSmithKline PLC's deferred tax assets (liabilities), net declined from 2008 to 2009 but then slightly increased from 2009 to 2010.
|
